ChemBriefASP Isotopes Inc. Balance Sheet Overview
ASP Isotopes Inc. presented its annual balance sheet data from 2022 to 2025, showing significant growth in total assets and equity.
Yahoo Finance UK · 2026-10-31 08:28
← TagsCompany
ASP Isotopes Inc. Common Stock
Aspire Real Estate Investors, Inc. focuses on investing, developing, remodeling and managing a portfolio of multi-family properties in metropolitan areas of the United States. The company is headquartered in Irvine, California.
164 articles
ASP Isotopes Inc. Seasonal Returns Chart
ASP Isotopes Inc. stock displays seasonal return trends from 2022 to 2026, priced at $2.02 on October 30 with minor after-hours recovery.
Yahoo Finance UK · 2026-10-30 11:59
ASPI: Scaling Isotope Production and Radiopharmacies Toward a $300M EBITDA Target by 2031
ASP Isotopes Inc. targets $300 million EBITDA by 2031 via isotope shipments, helium scale-up, and radiopharmacy acquisitions. The firm also pursues a VHH cancer-treatment pipeline within its expansion
TradingView · 2026-10-28 18:10
ASP Isotopes at Emerging Growth Conference 97: Scaling Critical Materials
At the Emerging Growth Conference 97, ASP Isotopes detailed its commercial growth strategy in helium, nuclear medicine, and semiconductor materials. Leveraging $250 million in cash, the company aims f
Investing.com · 2026-10-28 17:10
ASP Isotopes' Renergen achieves stable helium output at Virginia project
ASP Isotopes' subsidiary Renergen achieved stable liquid helium production at its Free State project, storing output for initial customer deliveries ahead of commercial launch. The company continues a
Business Day · 2026-10-27 03:10
ASP Isotopes’ Tetra4 begins stable liquid helium production
ASP Isotopes Inc. announced its subsidiary Tetra4 has begun stable liquid helium production at its Virginia Gas Project in South Africa. Full nameplate capacity is expected by Q4 2026, supporting exis
Investing.com · 2026-10-26 18:40
ASP Isotopes (NASDAQ:ASPI) Marks Stable Helium Production at Virginia Gas Project
ASP Isotopes announced stable liquid helium production at its Renergen Virginia Gas Project in South Africa, targeting 70,000 cubic feet daily with full capacity expected by Q4 2026.
Kalkine · 2026-10-26 13:11
ASP Isotopes Inc Files Form 8K on October 26
ASP Isotopes Inc filed a Form 8K with the SEC on October 26, signaling potential material events, though the announcement lacked specific operational details.
Investing.com India · 2026-10-26 13:11
ASP Isotopes Inc. Announces Stable Liquid Helium Production at Renergen Limited’s Virginia Gas Project
ASP Isotopes Inc.'s subsidiary Renergen Limited has achieved stable liquid helium production at its Virginia Gas Project in South Africa. The project targets 70 Mcf/day of liquid helium by Q4 2026 to
ASP Isotopes · 2026-10-26 08:00
ASP Isotopes Inc. CFO Files Form 4 on October 21
ASP Isotopes Inc. reported a Form 4 insider transaction filed by CFO Heather Kiessling on October 21.
Investing.com UK · 2026-10-23 01:40
Joint venture to produce HALEU in South Africa
ASP Isotopes Inc subsidiary Quantum Leap Energy and South African state-owned Necsa formed a joint venture to produce high-assay low-enriched uranium (HALEU) at Pelindaba, securing an off-take agreeme
World Nuclear News · 2026-10-20 08:42
ASP Isotopes COO Robert Ainscow Executes 22,500 Share Sale Under 10b5-1 Plan for Tax Coverage
ASP Isotopes COO Robert Ainscow sold 22,500 shares on Oct 14, 2026, via a 10b5-1 plan for taxes, retaining 2.2M shares.
Kalkine Media · 2026-10-17 02:11
ASP Isotopes Subsidiary Quantum Leap Energy Signs Heads of Agreement with Necsa for South Africa HALEU Joint Venture
ASP Isotopes' subsidiary Quantum Leap Energy partnered with South Africa's Necsa to develop a commercial HALEU production facility. QLE holds 80% ownership and has secured off-take agreements with Ter
Quiver Quantitative · 2026-10-15 12:40
ASP Isotopes Subsidiary Signs Binding Agreement with Necsa for HALEU JV
ASP Isotopes' subsidiary Quantum Leap Energy signed a binding agreement with Necsa to form a joint venture for HALEU production, with QLE holding 80% ownership and supported by off-take agreements wit
TradingView · 2026-10-15 12:09
ASP Isotopes Subsidiary Secures TerraPower Offtake for South African HALEU Project
ASP Isotopes' subsidiary Quantum Leap Energy formed a joint venture with Necsa to produce High-Assay Low-Enriched Uranium in South Africa, securing off-take agreements with TerraPower.
Stock Titan · 2026-10-15 12:09
ASP Isotopes Officer Plans to Sell 22,500 Shares to Cover Vesting Taxes
ASP Isotopes Inc. officer Robert Ainscow plans to sell 22,500 common shares valued at $46,575 to cover income tax liabilities from quarterly vesting under a Rule 10b5-1 trading plan.
Stock Titan · 2026-10-15 02:12
ASP Isotopes Inc. Files Form 144 on October 14
ASP Isotopes Inc. filed a Form 144 on October 14, indicating an insider's intent to sell restricted stock, according to Investing.com.
Investing.com Canada · 2026-10-14 10:02
ASP Isotopes Reports Beneficial Ownership Stake in ENDRA Life Sciences
ASP Isotopes Inc. disclosed a 15.1% beneficial ownership stake in ENDRA Life Sciences Inc., comprising common shares and pre-funded warrants. A proposed merger with Noble Africa LLC may grant ASP Isot
Stock Titan · 2026-10-09 04:10
ASP Isotopes Inc. Files Form 8K on October 2nd
ASP Isotopes Inc. filed a Form 8K on October 2nd, indicating a significant corporate event. Specific details of the disclosure require reviewing the official filing.
Investing.com Nigeria · 2026-10-02 14:59
ENDRA files S-4 for merger with ASP Isotopes subsidiary Noble Africa
ENDRA Life Sciences filed a Form S-4 registration statement to merge with Noble Africa, a subsidiary of ASP Isotopes. The deal aims to combine ASP's South African assets with a Nasdaq-listed entity pe
Dealroom · 2026-10-02 11:35
ENDRA Files S-4 for Proposed Merger with ASP Isotopes Unit Incorporating Renergen Disclosure
ENDRA filed a Form S-4 registration statement for its proposed merger with Noble Africa, a subsidiary of ASP Isotopes, incorporating material disclosures regarding Renergen and financial impacts.
TradingView · 2026-10-02 10:35
Director Purchases 15,000 Shares in ASP Isotopes (ASPI)
ASP Isotopes director Robert John Andrew Ryan purchased 15,000 shares at an average price of $2.68, raising his direct holdings to 675,222 shares. The acquisition occurred across multiple transactions
Stock Titan · 2026-10-01 21:26
ASP Isotopes Inc Files Form 4 Regulatory Document
ASP Isotopes Inc submitted a Form 4 regulatory filing on September 30, reflecting a 3.98% stock increase, according to an automated notification.
Investing.com Canada · 2026-09-30 11:35
ASP Isotopes Director Buys 8,000 Shares at $2.70 Average Price
ASP Isotopes Inc. director Robert John Andrew Ryan purchased 8,000 shares at an average price of $2.70 per share. The transaction was reported via Form 4, signaling positive insider sentiment.
Stock Titan · 2026-09-30 10:35
Total Revenue of ASP Isotopes, Inc. – HAN:W62
ASP Isotopes Inc. financial overview on the Hannover Stock Exchange shows a closed market with no trades, presenting an early-stage report structure without detailed revenue figures.
TradingView · 2026-09-29 19:56
ASP Isotopes shareholders urged to act on potential fiduciary breaches by company officers.
Halper Sadeh LLC is investigating ASP Isotopes Inc. officers for potential fiduciary breaches, offering free consultations to long-term shareholders seeking corporate governance reforms.
Pluang · 2026-09-29 02:03
ASP Isotopes Director Todd Wider Proposes Share Sale
ASP Isotopes director Todd Wider filed notice to sell 200,000 shares worth $590,000 via J.P. Morgan, following two prior sales in June 2026.
Stock Titan · 2026-09-25 20:22
ASP Isotopes Hosts Inaugural Capital Markets Day and Provides Operational Update
At its inaugural Capital Markets Day, ASP Isotopes outlined a strategy targeting $300 million EBITDA by 2031 through nuclear medicine, helium, and LNG production, with commercial shipments commencing
GlobeNewswire · 2026-09-11 11:52
ASP Isotopes hosts inaugural Capital Markets Day, outlines production milestones and $300M EBITDA 2031 target
ASP Isotopes targets $300 million EBITDA by 2031 following its inaugural Capital Markets Day, driven by liquid helium, radiopharmacy, and stable isotope commercialization. The company also announced p
TradingView · 2026-09-09 04:56
ASP Isotopes (ASPI) COO Sells Shares to Cover Taxes
ASP Isotopes Inc. COO Robert Ainscow sold 8,438 shares at $4.292 per share under a Rule 10b5-1 plan to cover tax withholding obligations on vested restricted stock awards.
Stock Titan · 2026-09-09 04:56